Rinvask Dosage/Direction for Use

General Dosage Information: The dosage range for Pitavastatin is 1 to 4 mg once daily, with or without food. The recommended starting dose is 2 mg, with a maximum dose of 4 mg. The initial and maintenance doses of Pitavastatin should be individualized according to patient characteristics and therapeutic goals or response. Lipid levels should be checked after 4 weeks of therapy, and the dose should be adjusted accordingly.
Use of Pitavastatin in children should only be prescribed by physicians experienced in treating hyperlipidemia, and efficacy should be reviewed periodically.
Dosage in Patients with Renal Impairment: Patients with moderate and severe renal impairment (glomerular filtration rate of 30-59 mL/min/1.73 m² and 15-29 mL/min/1.73 m², respectively, who are not receiving hemodialysis) and patients with end-stage renal disease receiving hemodialysis are recommended to receive an initial dose of Pitavastatin 1 mg once daily, with a maximum dose of 2 mg once daily.
The recommended dose in pediatric patients with a history of renal impairment has not been established.
Concomitant Use with Erythromycin: In patients taking erythromycin, Pitavastatin dosage should not exceed 1 mg once daily (see Interactions).
Concomitant Use with Rifampin: In patients taking rifampin, Pitavastatin dosage should not exceed 2 mg once daily (see Interactions).